PD1 (CD279) is an inhibitory co-receptor expressed on the cell surface of T lymphocytes CD8+ and CD4+, natural killer cells (NK), B lymphocytes and tumor-infiltrating lymphocytes (TILs) [14]. This evidence concerns the gene CD8A and neoplasm.